Evidence map›Paper›PMID 37900556›Full record

ArticleBreast care (Basel, Switzerland)2023

Primary Breast Sarcoma: A Two-Centre Analysis and Review of Literature.

Jan Žatecký, Oldřich Coufal, Pavel Fabian, Miloš Holánek, Eva Sehnálková, Petr Burkoň

Open access · greenAbstract read
In one paragraph

Article in Breast care (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jan ŽateckýDepartment of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Oldřich CoufalDepartment of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Pavel FabianDepartment of Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Miloš HolánekDepartment of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Eva SehnálkováThe Institute of Paramedical Health Studies, Faculty of Public Policies, Silesian University, Opava, Czech Republic.
Petr BurkoňDepartment of Radiation Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Masaryk University · CZSilesian University in Opava · CZMasaryk Memorial Cancer Institute · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Primary breast sarcoma is a very rare malignant type of breast tumours with an incidence of 0.1% of all primary breast malignancies. Methods: We present a retrospective analysis of the case series from two hospitals in the Czech Republic with a review of the diagnostic and treatment approach to primary breast sarcomas with an analysis of published prognostic factors. Results: Eleven patients were included in the study, 9 women and 2 men. Statistical evaluation revealed that tumour size ( Conclusion: The analysis did not prove any of the factors, such as age, tumour size, grade, or mitotic activity, to be statistically significant prognostic factors. Based on the literature review, the most common published prognostic factors are tumour size, margin status, and grade, but the results are ambiguous.

Indexed as

Primary breast sarcomaPrognostic factorsTwo-centre analysis

Identifiers

PMID37900556
PMCPMC10601702
OpenAlexW4386021516

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.